This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. from 2022 to 2031.
Abstract Worldwide, valvular heartdisease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
Objective Pulmonary hypertension (PHT) commonly coexists with significant mitral regurgitation (MR), but its prevalence and prognostic importance have not been well characterised. In a large cohort of adults with moderate or greater MR, we aimed to describe the prevalence and severity of PHT and assess its influence on outcomes.
Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Outcomes were worse with increasing surgical urgency, older age, dialysis dependence, and multiple reoperations.
It’s a celebration of the amazing innovation that has occurred in structural heartdisease therapy over the last 20 years and I’m proud to be part of it. Improving patient care and outcomes is what drives my commitment to helping find new solutions in the field.
On May, 25th 2018 (coinciding with Global Surgery Day), the World Health Organization (WHO) and its Member States unanimously accepted the Global Resolution on Rheumatic Fever and Rheumatic HeartDisease (RHD) at the World Health Assembly in Geneva, Switzerland. In these, case-fatality rates are as high as 5%.
Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heartdisease in Europe. Abstract Aims Tricuspid regurgitation (TR) is commonly observed in patients with severe left-sided valvular heartdisease (VHD).
“Edwards has a long history of leading innovation and pioneering new therapies to address the unmet needs of patients with structural heartdisease,” said Daveen Chopra , Edwards’ corporate vice president, transcatheter mitral and tricuspid therapies. “We
We know that structural heartdisease and heart failure are the leading causes of hospitalization and morbidity in the U.S. This milestone makes AISAP the first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heartdiseases using POCUS.
Henry Ford Health's Center for Structural HeartDisease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. Medical Director of Structural HeartDisease at Henry Ford Health. “We
The heart has four valves (aortic, mitral, pulmonic, and tricuspid) that open and close to move blood through the heart and to the rest of the body. If a valve cannot open or close fully it can interfere with blood flow and cause a host of health issues, including heart attack and stroke. and affects an estimated 1.6
“Until now, there was no available transcatheter treatment options for patients with tricuspid valve disease,” said Robert Kipperman, MD , interventional cardiologist and structural heartdisease specialist at Gagnon Cardiovascular Institute’s Valve Center at Morristown Medical Center , part of Atlantic Health System. “We
Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors. It is also frequently observed in AFMR patients, making it crucial to understand its impact on AFMR outcomes.
Journal of the American Heart Association, Ahead of Print. BackgroundMultimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. AF symptom severity was assessed via the University of Toronto AF Severity Scale questionnaire.
Cardiometabolic conditions – specifically obesity, diabetes and heartdisease – disproportionately affect the 60 million people in the U.S. Cultural customs like diet and lifestyle can be compounded by language barriers to create challenges in reducing the rates of these diseases. with Hispanic heritage. Register Now
It has been reported that the estimated burden of congenital heartdisease (CHD) in Ghana approximates 372 per million population , a disproportionally high number due to the higher fertility rate in the country relative to other countries in the Region. million people, with 10.95 million children (38.8% of total) under 15 years old.
1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications. tim.hodson Wed, 09/04/2024 - 15:53 Sept.
Getty Images milla1cf Tue, 01/16/2024 - 14:11 January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heartdisease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.
22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 HeartDisease and Stroke Statistical Update. Many people with HVD may not experience symptoms until the disease reaches an advanced stage.
Objective A substantial proportion of patients with rheumatic heartdisease (RHD) have tricuspid regurgitation (TR). This study aimed to identify the impact of functional TR on clinical outcomes and predictors of progression in a large population of patients with RHD. and severe in 4.3%. for moderate, and 2.30 (95% CI 1.28
The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
Abstract Aims Secondary mitral regurgitation (SMR) and tricuspid regurgitation (TR) are the most common valvular heartdiseases in patients with heart failure (HF). However, limitations in design, patient characterization, and outcomes reporting restrain their use.
In pregnant women with significant heartdisease : A quick LSCS or a potentially prolonged natural delivery,which is more safe ? For women with significant heartdisease (e.g., In women with significant heartdisease, the physiological demands of labor (e.g., Is LSCS really more safe ?
New onset harsh systolic murmur in a patient with subacute completed MI is VSR or papillary muscle rupture (with acute mitral regurgitation) until proven otherwise. How extensive was this patient's heartdisease prior to this recent event? When did the MI begin? When was the VSR?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content